Aterra Metals arranges $3.09-million private placement

Executive Summary

• Aterra Metals Inc. announced a non-brokered private placement financing to raise up to $3,090,411 through the sale of up to 154,520,550 units at $0.02 per unit.
• The offering is split into two tranches: up to 104,520,550 units under the Listed Issuer Financing Exemption (LIFE) and up to 50 million units under other prospectus exemptions.
• Proceeds will be used for exploration activities at the Frontera, Taruca, and Clinton properties, as well as working capital and general corporate purposes.

Key Details

• Total Gross Proceeds: Up to $3,090,411.
• Unit Price: $0.02 per unit.
• Total Units: Up to 154,520,550 units.
• Tranche 1 (LIFE): Up to 104,520,550 units for gross proceeds of up to $2,090,411, issued pursuant to the Listed Issuer Financing Exemption (LIFE) under NI 45-106. These units are not subject to resale restrictions.
• Tranche 2 (Other Exemptions): Up to 50 million units for gross proceeds of up to $1,000,000, issued on a prospectus-exempt basis other than LIFE. These shares and warrants are subject to a statutory hold period of four months and one day.
• Warrant Terms: Each unit includes one warrant. Each warrant entitles the holder to acquire one common share at an exercise price of $0.05 per share.
• Warrant Expiry: 36 months from the date of issuance.
• Warrant Lock-up: Warrants are not exercisable for 60 days following the closing of the offerings.
• Finder: Research Capital Corp. appointed as exclusive finder.
• Finder’s Fee: Up to 7% of gross proceeds from introduced purchasers, payable in cash or shares.
• Insider Participation: Certain insiders intend to subscribe for up to 7.5 million units. This is a related party transaction exempt from formal valuation and minority shareholder approval requirements under MI 61-101, as the fair market value is not more than 25% of the company's market capitalization.
• Use of Proceeds: Financing option payments and exploration at Frontera, Taruca, and Clinton properties; working capital; and general corporate purposes.
• Closing Date: Expected on or about the week of Jan. 12, 2026.
• Conditions Precedent: Receipt of necessary regulatory approvals (CSE and applicable securities authorities) and shareholder approval via written resolution (majority of outstanding shares).

Notable Quotes

• None provided in the text.